Natixis

SEC CIK: 0001274981
Latest filing: Aug 13, 2026

SEC filings (opens in a new tab)

AVTX holding history

Avalo Therapeutics, Inc. in every 13F filed by Natixis, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

AVTX overview All 13F holders of AVTX Full Q2 2026 holdings

Shares (Q2 2024): 0; Sold out in Q2 2024
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q4 2023

Holdings of AVTX by Natixis, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2024	0	$0	0.0%	−2,512−100.0%	Sold out	Holders
Q1 2024	2,512	$54.6K	<0.1%	−2,092−45.4%	Reduced	Holders
Q4 2023	4,604	$43.3K	<0.1%	+4,604	New	Holders